Subscribe to our Newsletters !!

    Kumar Jeetendra

    Mass spectrometry shows potential for fast SARS-CoV-2 recognition

    A team from SPI in Marcoule discovered by mass spectrometry, in just 3 minutes and without specific reagents, signature peptides of the SARS-CoV-2 virus in clinical samples (nasopharyngeal swabs). It hence gives a proof of concept concerning the usage of the technique as a potential option to PCR, now the reference process. Quick but nonetheless

    Putin says Russia grows first antibody against coronavirus

    Moscow, Aug 11 (PTI) Russian President Vladimir Putin on Tuesday declared that his nation has developed first vaccine that”works very effectively” and”forms a steady immunity” against COVID-19 as he disclosed that one of his daughters has been vaccinated. Putin made the claim in a government meeting where he described it as”a very significant step for

    Cipla scales up assembling of remdesivir to fulfill high need

    Medicine manufacturer Cipla said on Tuesday it is rising up the production of antiviral drug remdesivir, used in COVID-19 treatment, by manufacturing the drug at its Goa plant. “Presently the requirement is enormous for remdesivir, also we’re scaling up our internal production of Remdesivir,” Kedar Upadhye, global chief financial officer of Cipla, told Moneycontrol. Upadhye

    New Sustainable Laboratory Solutions handout from Scientific Laboratory Supplies (SLS)

    After months of research to what their customers are actually searching for, from a provider, seeing sustainability within the lab surroundings SLS have brought together some really useful information to assist lab employees realise their green objectives. The booklet (which is printed on carbon balanced FSC certified paper utilizing sustainable printing practices) is a handy

    Model Blood Test Could Detect Brain Damage Within Hours of Birth

    An ancient blood test may discover which babies deprived of oxygen at birth are at risk of severe neurodisabilities like cerebral palsy and epilepsy.1 The prototype test looks for certain genes being switched on and off that are linked to long-term neurological issues. Further investigations of the genes may provide new targets for treating the

    Germany says Russian COVID-19 immunization has not been adequately tried

    German Health Minister Jens Spahn on Wednesday stated Russia’s COVID-19 vaccine had not been satisfactorily tested, including the goal would be to have a safe product instead of simply being first to start vaccinating people. President Vladimir Putin declared on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19

    Study: Anti-microRNA sedate essentially lessens miR-92a levels in human peripheral blood

    A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels from the blood of healthy humans. “According to documented, promising therapeutic possible, locked nucleic acid (LNA)-based anti-miR-92a was further developed and tested in a first in human analysis,” said Stefanie Dimmeler, PhD, Goethe University, Frankfurt, Germany and coauthors. “MRG-110 caused de-repression of

    Solid Link Between Abnormal Liver Tests and Poor Covid-19 Outcomes

    Researchers at the Yale Liver Center found that patients using covid-19 demonstrated with abnormal liver tests at much greater rates than indicated by earlier studies.1 They also discovered that higher levels of liver enzymes–proteins released when the liver is damaged–were associated with poorer outcomes for these patients, including ICU admission, mechanical ventilation, and death. Past

    Peak Scientific presents new gas generator and bench solutions for the SCIEX 7500 LC-MS framework

    Peak Scientific, the global leader in gas production for laboratories, has introduced its latest nitrogen gas generator innovations with the launching of a new package of products engineered to encourage SCIEX’s recently released Mass Spectrometry platforms. Produced in cooperation with and exclusively for SCIEX, the new suite of products comes in three versions, each analyzed